T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-19-023 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to enhance the participation of individuals from diverse backgrounds underrepresented in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum. The NHLBIs T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutiona...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 27, 2018 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3)
Notice NOT-HL-18-624 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2018 Category: Research Source Type: funding
NSF/VMware Partnership on Edge Computing Data Infrastructure (ECDI)
Full Proposal Deadline Date: May 22, 2018 Program Guidelines: NSF 18-540The proliferation of mobile and Internet-of-Things (IoT) devices, and their pervasiveness across nearly every sphere of our society, continues to raise questions about the architectures that organize tomorrow’s compute infrastructure. At the heart of this trend is the data that will be generated as myriad devices and application services operate simultaneously to digitize a complex domain like a smart building or smart industrial facility. A key shift is from edge devices consuming ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=50550...
Source: NSF Upcoming Due Dates - April 22, 2018 Category: Science Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3)
Notice NOT-HL-18-620 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 13, 2018 Category: Research Source Type: funding
Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)
Funding Opportunity RFA-HL-19-015 from the NIH Guide for Grants and Contracts. The Physician-Scientist Research Award for Early Stage Investigators is intended to support the independence of physician-scientist faculty committed to academic careers in heart, lung, and blood diseases, and sleep disorders and related implementation research. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 30, 2018 Category: Research Source Type: funding
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
Funding Opportunity PAS-18-730 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is calling for R01 grant applications in nonmalignant hematology research. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build and promote research activities in nonmalignant hematology. Innovative research project applications that will steer the field in new directions are invited. Each project will propose proof of principle research that is tightly...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 29, 2018 Category: Research Source Type: funding
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) is calling for R01 grant applications in nonmalignant hematology research. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build and promote research activities in nonmalignant hematology. Innovative research project applications that will steer the field in new directions are invited. Each project will propose proof of principle research that is tightly focused into one specific aim and is directed at validating novel concepts and...
Source: NIDDK Funding Opportunities - March 29, 2018 Category: Endocrinology Source Type: funding
Notice of Technical Assistance Webinar for RFA-HL-19-014: Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE)
Notice NOT-HL-18-605 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 19, 2018 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Cardiothoracic Surgical Trials Network Renewal (UM1)
Notice NOT-HL-18-606 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 16, 2018 Category: Research Source Type: funding
Notice of Intent to Fund a Strong Heart Study Phase VII Exam
Notice NOT-HL-18-607 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 16, 2018 Category: Research Source Type: funding
Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders (R43 - Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-19-016 from the NIH Guide for Grants and Contracts. This FOA encourages new R43 applications for design and development of technologies to monitor health or deliver care in a real-time, accessible, effective, and minimally obtrusive way for aging adults. These may be novel sensor or monitoring systems, home-use point-of-care devices, home or mobile therapy or rehabilitation tools, or information systems and should have the goal of fostering healthy and independent living. The development of such technologies should incorporate specific human factors for people with disabilities, people aging w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2018 Category: Research Source Type: funding
Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-19-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks late-stage T4 Translation research (T4TR) and implementation studies that will lead to generalizable new knowledge to accelerate the adoption/adaptation, and sustained, high-fidelity use of proven-effective interventions for the prevention, treatment, and control of heart, lung, blood, and sleep disorders or diseases (HLBS conditions). It calls for multi-level strategies for delivery of proven-effective interventions to promote the prevention and management of HLBS conditions. The system-level...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 5, 2018 Category: Research Source Type: funding
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applications submitted to this FOA must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website: http://www.nhlbi.nih.gov. This FOA will uti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 27, 2018 Category: Research Source Type: funding
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required)
The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applications submitted to this FOA must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website: http://www.nhlbi.nih.gov. This FOA will uti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 27, 2018 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Cardiothoracic Surgical Trials Network Renewal - CCC (U10 - Clinical Trials Required)
Notice NOT-HL-18-588 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 12, 2018 Category: Research Source Type: funding
